GSK股價下跌，法院裁決Zantac訴訟繼續進行

Reported 4 months ago

GSK股價在法院裁定70,000多宗訴訟指控心口痛藥Zantac可能導致癌症後下滑，即將進入周一開盤交易。雖然GSK今年表現良好，但此次訴訟可能帶來財務壓力。股票下跌，但分析師對GSK仍持積極態度。

You may also interested in these wikis

Dividend Investor Doubles Monthly Income to $1,000 Reveals Top High-Yield Stocks

Consider the Vanguard Growth ETF for Investing in Nvidia, Microsoft, and Apple

USDA Investigates Handling of Boar's Head Listeria Outbreak

Comparing AI Stocks: Palantir vs. UiPath

Nassim Taleb Warns of Potential Market Collapse as Fragility Peaks in 20 Years

Nvidia Nears Record High as DJT Stock Rallies: Yahoo Finance

Wedbush Upgrades Affirm and Upstart to Neutral

Exploring More Sustainable Dividend Options Beyond Medical Properties Trust

Earnings Insights: UnitedHealth, Walgreens, and Johnson & Johnson Report

Jim Cramer Expresses Concern for Boeing After 17,000 Job Cuts Amid Safety Issues

Back to all Wikis